microdosing glp 1 for menopause GLP‑1 in & Perimenopause Why GLP-1 Microdosing? A Closer

Julius Few, MD The approach: How to support GLP-1 patients Patients dont just want answers

I was interested to read a new report highlighting the possible benefits of a diabetes drug known as tirzepatide in a man with male pattern balding or androgenetic alopecia

As amylin and GLP-1 target different populations of neurons in the DVC 20 , this suggests that combination drug therapies affecting both systems may provide a greater magnitude and sustainable degree of weight loss compared to monotherapies due to a reduced likelihood of tachyphylaxis 21,22,23

GLP-1 receptor agonists (GLP-1RAs) like semaglutide and tirzepatide are increasingly used in clinical practice, given their proven efficacy in managing obesity and type 2 diabetes (T2D) [1]

It should be compulsory

For employers who cover these medications, the budgetary impact is real and growing